Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.80 +0.00 (+0.57%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Revenue (2020 - 2026)

Updated

Rani Therapeutics Holdings' Revenue came in at $1.71 million for Q2 2026, unchanged from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Revenue (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Rani Therapeutics Holdings reported Revenue of $4.88 million, up 306.4% year-over-year; for FY2025, it was $1.63 million, up 58.9% from FY2024.

  • Revenue carries a five-year compound annual growth rate of 28.7% (FY2020 to FY2025).
  • Going back by year, Revenue was $1.03 million in FY2024 and $2.72 million in FY2021 (+488.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - 1.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.71 Mn
Mar 31, 2026 1.71 Mn
Dec 31, 2025 1.46 Mn
Mar 31, 2025 172,000.00
Dec 31, 2024 1.03 Mn
Jun 30, 2021 1.96 Mn
Mar 31, 2021 756,000.00
Dec 31, 2020 210,000.00
Sep 30, 2020 108,000.00
Jun 30, 2020 60,000.00
API Access

Rani Therapeutics Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RANI&period=max&api_key=YOUR_API_KEY